14 Results

People

  1. Arbour
    Arbour
  2. Riely
    Riely
  3. Hellmann
    Hellmann
  4. Kris
    Kris
  5. Ladanyi
    Ladanyi
  6. Lito
    Lito
  7. Rizvi
    Rizvi
  8. Rudin
    Rudin
  9. Arcila
    Arcila
  10. Plodkowski
    Plodkowski

Groups

  1. Department of Medicine (14)
  2. Solid Tumor Oncology Division (14)
  3. Thoracic Oncology (14)
  4. GSK Faculty (6)
  5. Human Oncology and Pathogenesis Program (6)
  6. Biostatistics Service (5)
  7. Epidemiology and Biostatistics (5)
  8. Radiology, Department of (5)
  9. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (4)
  10. Body Imaging Service (4)
  1. "human"
  2. "Kathryn Arbour"
  3. "Thoracic Oncology"
Formats
  1. Journal Article (12)
  2. Editorial (1)
  3. Review (1)
Groups
  1. Department of Medicine (14)
  2. Solid Tumor Oncology Division (14)
  3. Thoracic Oncology (14)
  4. GSK Faculty (6)
  5. Human Oncology and Pathogenesis Program (6)
  6. Biostatistics Service (5)

More Groups

People
  1. Kathryn Arbour (14)
  2. Gregory Riely (9)
  3. Matthew Hellmann (5)
  4. Charles Rudin (4)
  5. Hira Rizvi (4)
  6. Marc Ladanyi (4)

More People

Years
  1. 2023 (4)
  2. 2022 (4)
  3. 2020 (2)
  4. 2019 (1)
  5. 2018 (3)
Publications
  1. Annals of Oncology (3)
  2. Cancer (2)
  3. Clinical Cancer Research (2)
  4. Cancer Discovery (1)
  5. Cancer Research (1)
  6. JAMA - Journal of the American Medical Association (1)

More Publications

Publishers
  1. American Association for Cancer Research (4)
  2. Oxford University Press (4)
  3. Wiley Blackwell (2)
  4. American Medical Association (1)
  5. American Society of Clinical Oncology (1)
  6. Massachusetts Medical Society (1)

More Publishers

Results (14)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Outcomes of combination platinum-doublet chemotherapy and anti-PD(L)-1 blockade in KRAS(G12C) mutant non-small cell lung cancer
    Journal Article

    Elkrief, A.; Riccuiti, B.; Alessi, J. V.; Fei, T.; Kalvin, H. L.; Egger, J. V.; Rizvi, H.; Thummalapalli, R.; Lamberti, G.; Plodkowski, A.; more...
    The Oncologist (2023)

    Fulltext@MSK | Save
  • MRTX1719 is an MTA-cooperative PRMT5 inhibitor that exhibits synthetic lethality in preclinical models and patients with MTAP-deleted cancer
    Journal Article

    Engstrom, L. D.; Aranda, R.; Waters, L.; Moya, K.; Bowcut, V.; Vegar, L.; Trinh, D.; Hebbert, A.; Smith, C. R.; Kulyk, S.; more...
    Cancer Discovery (2023)

    Fulltext@MSK | Save
  • The GENIE BPC NSCLC cohort: A real-world repository integrating standardized clinical and genomic data for 1,846 patients with non-small cell lung cancer
    Journal Article

    Choudhury, N. J.; Lavery, J. A.; Brown, S.; de Bruijn, I.; Jee, J.; Tran, T. N.; Rizvi, H.; Arbour, K. C.; Whiting, K.; Shen, R.; more...
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save
  • Single-agent Divarasib (GDC-6036) in solid tumors with a KRAS G12C mutation
    Journal Article

    Sacher, A.; LoRusso, P.; Patel, M. R.; Miller, W. H.; Garralda, E.; Forster, M. D.; Santoro, A.; Falcon, A.; Kim, T. W.; Paz-Ares, L.; more...
    New England Journal of Medicine (2023)

    Fulltext@MSK | Save
  • Overall survival with circulating tumor DNA-guided therapy in advanced non-small-cell lung cancer
    Journal Article

    Jee, J.; Lebow, E. S.; Yeh, R.; Das, J. P.; Namakydoust, A.; Paik, P. K.; Chaft, J. E.; Jayakumaran, G.; Brannon, A. R.; Benayed, R.; more...
    Nature Medicine (2022)

    Fulltext@MSK | Save
  • Genomic landscapes and hallmarks of mutant RAS in human cancers
    Journal Article

    Scharpf, R. B.; Balan, A.; Ricciuti, B.; Fiksel, J.; Cherry, C.; Wang, C.; Lenoue-Newton, M. L.; Rizvi, H. A.; White, J. R.; Baras, A. S.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Dissecting the clinicopathologic, genomic, and immunophenotypic correlates of KRAS(G12D)-mutated non-small-cell lung cancer
    Journal Article

    Ricciuti, B.; Alessi, J. V.; Elkrief, A.; Wang, X.; Cortellini, A.; Li, Y. Y.; Vaz, V. R.; Gupta, H.; Pecci, F.; Barrichello, A.; more...
    Annals of Oncology (2022)

    Fulltext@MSK | Save
  • Expanding the arsenal of clinically active KRAS G12C inhibitors
    Editorial

    Arbour, K. C.; Lito, P.
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Clinical and molecular correlates of PD-L1 expression in patients with lung adenocarcinomas
    Journal Article

    Schoenfeld, A. J.; Rizvi, H.; Bandlamudi, C.; Sauter, J. L.; Travis, W. D.; Rekhtman, N.; Plodkowski, A. J.; Perez-Johnston, R.; Sawan, P.; Beras, A.; more...
    Annals of Oncology (2020)

    Fulltext@MSK | Save
  • Clinical activity of programmed cell death 1 (PD-1) blockade in never, light, and heavy smokers with non-small-cell lung cancer and PD-L1 expression ≥50%
    Journal Article

    Gainor, J. F.; Rizvi, H.; Jimenez Aguilar, E.; Skoulidis, F.; Yeap, B. Y.; Naidoo, J.; Khosrowjerdi, S.; Mooradian, M.; Lydon, C.; Illei, P.; more...
    Annals of Oncology (2020)

    Fulltext@MSK | Save